Skip to main content
Equibles

RENAISSANCE TECHNOLOGIES LLC

Position in CPHI — China Pharma Holdings, Inc.

CIK 1037389 NEW YORK, NY
Back to CPHI Full portfolio

Position in CPHI

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$9,929
+$2,965 QoQ
Shares Held
15,045
+31.8% QoQ
Ownership
0.035%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#3
of 8 holders
Holding Since
Mar 2020
20 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CPHI Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

RENAISSANCE TECHNOLOGIES LLC holds $2,242,873,379 across 49 Drug Manufacturers - Specialty & Generic names. CPHI ranks #48 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 UTHR
UNITED THERAPEUTICS Corp
 1,708,739 $925,846,052
2 NBIX
Neurocrine Biosciences Inc
 2,335,897 $393,692,080
3 ALKS
Alkermes plc.
 6,460,928 $338,552,627
4 RDY
Dr Reddys Laboratories Ltd
 7,347,028 $106,458,435
5 ZTS
Zoetis Inc.
 1,403,300 $100,841,138
6 SUPN
Supernus Pharmaceuticals, Inc.
 1,478,180 $68,750,151
7 COLL
Collegium Pharmaceutical, Inc
 1,366,549 $49,469,073
8 PCRX
Pacira BioSciences, Inc.
 1,733,801 $43,986,531

All Filings in CPHI

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $9,929 15,045
2026-03-31 $6,964 11,418
2025-12-31 $13,694 11,318
2025-09-30 $20,705 10,618
2025-03-31 $11,986 46,100
2023-09-30 $4,639 30,930
2023-06-30 $21,709 63,850
2023-03-31 $66,440 170,361
2022-12-31 $34,041 340,417
2022-09-30 $47,379 364,459
2022-06-30 $66,950 318,812
2022-03-31 $138,300 354,617
2021-12-31 $220,904 460,217
2021-09-30 $392,363 700,649
2021-06-30 $350,984 487,479
2021-03-31 $426,114 507,279
2020-12-31 $357,245 793,879
2020-09-30 $262,288 728,580
2020-06-30 $561,513 838,080
2020-03-31 $475,040 950,080